Compounds > ci 988
Page last updated: 2024-09-02

ci 988 and pd 135158

ci 988 has been researched along with pd 135158 in 6 studies

Compound Research Comparison

Studies
(ci 988)		Trials
(ci 988)		Recent Studies (post-2010)
(ci 988)		Studies
(pd 135158)		Trials
(pd 135158)		Recent Studies (post-2010) (pd 135158)
1478145100

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costall, B; Domeney, AM; Hughes, J; Kelly, ME; Naylor, RJ; Woodruff, GN1
Boden, P; Costall, B; Domeney, A; Horwell, DC; Hughes, J; Hunter, JC; Kelly, E; Pinnock, RD; Woodruff, GN1
Chen, D; Ding, XQ; Håkanson, R1
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE1
Little, HJ; Wilson, J1
Little, HJ; Watson, WP; Wilson, J1

Other Studies

6 other study(ies) available for ci 988 and pd 135158

ArticleYear
Anxiolytic effects of CCK-B antagonists.
    Neuropeptides, 1991, Volume: 19 Suppl

    Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Callitrichinae; Diazepam; Indoles; Meglumine; Mice; Rats; Receptors, Cholecystokinin; Substance Withdrawal Syndrome

1991
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
    Proceedings of the National Academy of Sciences of the United States of America, 1990, Volume: 87, Issue:17

    Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Callitrichinae; Cell Membrane; Cerebral Cortex; Cholecystokinin; Electrophysiology; Humans; Indoles; Kinetics; Meglumine; Mice; Pancreas; Rats; Receptors, Cholecystokinin; Social Behavior; Sorbitol; Ventromedial Hypothalamic Nucleus

1990
Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Gastroenterology, 1995, Volume: 109, Issue:4

    Topics: Animals; Benzodiazepinones; Devazepide; Enzyme Activation; Gastrins; Histidine Decarboxylase; Indoles; Ligands; Male; Meglumine; Phenethylamines; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Stomach

1995
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    International journal of cancer, 1994, May-01, Volume: 57, Issue:3

    Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor

1994
CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:4

    Topics: Acoustic Stimulation; Alcoholism; Animals; Anti-Anxiety Agents; Behavior, Animal; Central Nervous System Depressants; Dipeptides; Ethanol; Excitatory Amino Acid Agonists; Handling, Psychological; Indoles; Male; Meglumine; Mice; Mice, Inbred Strains; N-Methylaspartate; Receptors, Cholecystokinin; Seizures; Substance Withdrawal Syndrome

1998
CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.
    Psychopharmacology, 1998, Volume: 137, Issue:2

    Topics: Animals; Anxiety; Dipeptides; Ethanol; Indoles; Male; Maze Learning; Meglumine; Mice; Motor Activity; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Serotonin; Substance Withdrawal Syndrome

1998